SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Mary Shelley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Mary Shelley |
|---|
| Date of birth | 1797-08-30 |
|---|
| Identifiers | MRN HR-NI028-SYN-TD; SSN (made up) 000-28-6194 |
|---|
| Document date | 1849-07-07 |
|---|
| Author | Rosamund Achterberg-Ilesanmi, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Three-month MRI review after resection. [S]
History of Present Illness
Ms. Shelley returns three months after resection of a grade 1 meningioma. The MRI five days ago shows no residual or recurrent tumor, the swelling has resolved, and there is only a small scar under the craniotomy. She finished occupational therapy, and her right hand now feels as it did years ago; she writes for two to three hours each morning. She has had no seizure for sixteen weeks. The irritability has faded, and she has seen the counselor six times, talking about the illness and about old losses she has never spoken of to a clinician. Dr. Ferreira-Lindgren saw her after the scan and found no reason, from the surgery, against driving. [S]
| Element | Detail |
|---|
| MRI | No residual or recurrent tumor; edema resolved |
| Seizures | None for sixteen weeks |
| Hand | Full strength; writing two to three hours a day |
| Mood | Irritability faded; six counselor sessions |
Review of Systems
| System | Result | Finding |
|---|
| Neurological | Negative | No seizures, aura, weakness, or headaches |
| Psychiatric | Negative | Mood better; no irritability; no thoughts of suicide |
| Constitutional | Negative | Energy back; weight stable |
| Integumentary | Negative | Scar healed |
4 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Levetiracetam 500 mg oral tablet, one tablet by mouth twice a day | One tablet twice a day | Oral route | 1849-03-17 | active | S |
| Dexamethasone 4 mg oral tablet, one tablet twice a day for three days before surgery, then tapered and stopped over ten days after surgery | One tablet twice a day, then tapering | Oral route | 1849-04-04 to 1849-04-17 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for headache or wound pain, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 1848-09-01 | active | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1849-07-07 | Body height | 160 | cm | S |
| 1849-07-07 | Body weight | 57.6 | kg | S |
| 1849-07-07 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1849-07-07 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1849-07-07 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1849-07-07 | Heart rate | 70 | /min | S |
| 1849-07-07 | Respiratory rate | 14 | /min | S |
| 1849-07-07 | Body temperature | 36.6 | Cel | S |
| 1849-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1849-07-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | | | S |
| 1849-07-07 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | | | S |
Physical Exam
Vital signs recorded on 1849-07-07; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Well and cheerful |
| Neurological | Speech normal; grip, finger extension, and finger tapping equal on both sides; no drift; reflexes symmetric |
| Mental status | Mood "steadier"; affect bright; no thoughts of suicide |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Headaches, worse in the morning, for about two years, with episodes over six months of tingling and weakness of the right hand and leg lasting a few minutes, one with twitching of the right fingers and one with difficulty finding words; mild right-hand weakness on examination; cause not yet established; urgent MRI and EEG booked | resolved | confirmed |
R29.818 | S — Synthetic presenting concern at the index visit, superseded by the MRI and EEG diagnosis; her documented headaches with transient right-sided paralysis from 1839 are echoed. |
| Meningioma of the left frontoparietal convexity over the hand area of the motor cortex, 3.1 x 2.7 x 2.6 cm, with moderate vasogenic edema; resected (Simpson grade I); meningothelial meningioma, CNS WHO grade 1; synthetic modern counterpart of the supposed tumour of the left hemisphere on her death certificate | active | confirmed |
D32.0 | S — Synthetic modern diagnosis. Her symptoms and the certificate's wording are documented (D); a brain tumour is a retrospective interpretation (R) disputed by the hemiplegic migraine and stroke hypothesis, and no tissue exists, so this meningioma is not presented as her historical diagnosis. |
| Focal epilepsy due to the left convexity meningioma: focal aware sensory and motor seizures of the right hand and arm, one with speech arrest; EEG with left central sharp waves; on levetiracetam | active | confirmed |
G40.109 | S — Synthetic modern diagnosis echoing her documented convulsive seizures and transient right-sided paralysis; the hemiplegic migraine interpretation is recorded as R. |
Assessment and Plan
- Meningioma, CNS WHO grade 1, after resection (D32.0). No residual or recurrent tumor at three months. [S]
- Next MRI one year after surgery, then yearly to five years.
- Focal epilepsy on levetiracetam (G40.109). Seizure-free for sixteen weeks with resolving side effects. PHQ-9 6 and GAD-7 5. Her state's seizure-free requirement of three months is met, and the neurosurgeon has cleared her to drive. [S]
- Continue levetiracetam 500 mg twice a day; at one year after surgery, an EEG and a discussion of tapering.
- She may drive again; no driving for at least three months after any seizure, and never after a missed dose with symptoms.
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|
| Imaging | Surveillance MRI with gadolinium | Three months after resection, then yearly for five years, then every two years | Completed today | Five days ago: no residual or recurrent tumor; reviewed with her today |
| Self-management | Seizure diary, triggers (sleep loss, alcohol, missed doses), and seizure first aid | Every visit | Completed today | No seizures for sixteen weeks; no missed doses |
| Survey | PHQ-9, with a question about irritability on levetiracetam | Every visit while on levetiracetam and during cancer treatment | Completed today | 6, improving; irritability faded |
| Survey | GAD-7 | Every visit during the diagnostic and treatment phase | Completed today | 5, mild, done as the corrective action recorded at the last visit |
| Medication safety | Levetiracetam tolerability | Every visit | Completed today | Irritability resolved; no sleepiness or dizziness |
| Self-management | Driving | After the state's seizure-free period and surgical clearance | Completed today | Three months seizure-free and cleared by neurosurgery; may drive |
| Referral | Occupational therapy | Until hand function recovers | Completed today | Course finished; full function |
Goal progress:
- A diagnosis within two weeks, explained in plain words with the images and reports. Outcome by 1849-03-17: MRI and EEG within a week; diagnosis explained at two weeks with the images [S]
- No further seizures. In progress; target 1850-04-07 [S]
- Full use of the right hand and return to writing every morning. In progress; target 1849-09-29 [S]
- Decide on treatment herself after hearing the options, benefits, and harms. Outcome by 1849-03-17: Chose resection after observation and radiosurgery were explained [S]
- Mood and grief supported: PHQ-9 below 5 and a counselor available. In progress; target 1849-09-29 [S]
Guideline basis: EANO guideline on the diagnosis and management of meningiomas. Goldbrunner R, et al. Neuro Oncol 2021;23(11):1821-1834 (2021); NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers, Version 2.2025 (2025); Evidence-based guideline: Management of an unprovoked first seizure in adults. Krumholz A, et al. Neurology 2015;84(16):1705-1713 (2015); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (depression screening and PHQ-9 follow-up) (2026)
Follow-up: Review in about twelve weeks; counselor as she wishes; MRI one year after surgery. Next scheduled visit 1849-09-29: six-month review after resection: seizures, mood, and writing. [S]